Evaluation of the associations between the single nucleotide polymorphisms of the promoter region of the tumor necrosis factor-α gene and nasopharyngeal carcinoma

Journal of the Chinese Medical Association

Volumn 69, Issue 8, 2006, Pages 351-357

  Ho, Sheng Yow ^a,b   Wang, Ying Jan ^b   Huang, Po Chang ^a   Tsai, Sen Tien ^b   Chen, Chih Hung ^b   Chen, Helen H W ^b   Chang, Chih Jen ^b   Guo, How Ran ^b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Allele; Nasopharyngeal neoplasm; Single nucleotide polymorphism; Tumor necrosis factor

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALLELE; ARTICLE; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 33748505667     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(09)70272-2     Document Type: Article

References (36)

1. Shanmugaratnam K, Chan SH, de-The G, Goh JE, Khor TH, Simons MJ, Tye CY. Histopathology of nasopharyngeal carcinoma: correlations with epidemiology, survival rates and other biological characteristics. Cancer 1979;44:1029-44.
2. Chen CJ, Liang KY, Chang YS, Wang YF, Hsieh T, Hsu MM, Chen JY, et al. Multiple risk factors of nasopharyngeal carcinoma: Epstein-Barr virus, malarial infection, cigarette smoking and familial tendency. Anticancer Res 1990;10:547-53.
3. Hildesheim A, Anderson LM, Chen CJ, Cheng YJ, Brinton LA, Daly AK, Reed CD, et al. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 1997;89:1207-12.
4. Nazar-Stewart V, Vaughan TL, Burt RD, Chen C, Berwick M, Swanson GM. Glutathione S-transferase M1 and susceptibility to nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 1999;8:547-51.
5. Cho EY, Hildesheim A, Chen CJ, Hsu MM, Chen IH, Mittl BF, Levine PH, et al. Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol Biomarkers Prev 2003;12:1100-4.
6. Wu SB, Hwang SJ, Chang AS, Hsieh T, Hsu MM, Hsieh RP, Chen CJ, et al. Human leukocyte antigen (HLA) frequency among patients with nasopharyngeal carcinoma in Taiwan. Anticancer Res 1989;9:1649-53.
7. Hildesheim A, Apple RJ, Chen CJ, Wang SS, Cheng YJ, Klitz W, Mack SJ, et al. Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 2002;94:1780-9.
8. Szlosarek PW, Balkwill FR. Tumor necrosis factor a: a potential target for the therapy of solid tumors. Lancet Oncol 2003; 4:565-73.
9. Abrahamsson J, Carlsson B, Mellander L. Tumor necrosis factor-alpha in malignant disease. Am J Pediatr Hematol Oncol 1993;15:364-9.
10. Partanen R, Koskinen H, Hemminki K. Tumor necrosis factor-alpha (TNF-alpha) in patients who have asbestosis and develop cancer. Occup Environ Med 1995;52:316-9.
11. Komori A, Yatsunami J, Suganuma M, Okabe S, Abe S, Sakai A, Sasaki K, et al. Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation. Cancer Res 1993; 53:1982-5.
12. Garcia FU, Chen H-L, Yang Y, Pace JL, Hu X-L, Hunt JS. Tumor necrosis factor-alpha mRNA and protein in endometrial tumors: analysis by in situ hybridization and immunocytochemistry. Hum Pathol 1994;25:1324-31.
13. Knight B, Yech GC, Husk KL, Ly T, Abraham LJ, Yu C, Rhim JA, et al. Impaired pre-neoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J Exp Med 2000;192:1809-18
14. Baena A, Leung JY, Sullivan AD, Landires I, Vasquez-Luna N, Quinones-Berrocal J, Fraser PA, et al. TNF-alpha promoter single nucleotide polymorphisms are markers of human ancestry. Genes Immun 2002;3:482-7.
15. Chouchane L, Ben Ahmed S, Baccouche S, Remadi S. Polymorphism in tumor necrosis factor-α promoter region and in the heat shock protein 70 genes associated with malignant tumors. Cancer 1997;80:1489-96.
16. Oh BR, Sasaki M, Perinchery G, Ryu SB, Park YI, Carroll P, Dahiya R. Frequent genotype changes at -308 and 488 regions of the tumor necrosis factor-α (TNF-α) gene in patients with prostate cancer. J Urol 2000;163:1584-7.
17. Jang WH, Yang YI, Yea SS, Lee YJ, Chun JH, Kim HI, Kim MS, et al. The -238 tumor necrosis factor-α promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett 2001;166:41-6.
18. Ho SY, Wang YJ, Chen HL, Chen CH, Chang CJ, Wang PJ, Chen HHW, et al. Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor-α promoter gene. Cancer Causes Control 2004;15:657-63.
19. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-α promoter polymorphism effects transcription. Mol Immunol 1997;34:391-9.
20. Wilson AG, de Vaies N, Paciot F, Giovine FS, van der Putt LBA, Duff GW. An allelic polymorphism within the human HLA-A1, B8, and DR3 alleles. J Exp Med 1993;177:557-60.
21. Kaluza W, Reuss E, Grossmann S, Hug R, Schopf RE, Galle PR, Maerker-Hermann E, et al. Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism. J Invest Dermatol 2000;114:1180-3.
22. Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H, Itoh K. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 1998;51:605-12.
23. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, O'Sullivan B, et al. American Joint Committee on Cancer. AJCC Cancer Staging Manual, 5th edition. Philadelphia: Lippincott-Raven, 1997:31-9.
24. Tsai MH, Chen WC, Tsai FJ. Correlation of p21 gene codon 31 polymorphism and TNF-alpha gene polymorphism with nasopharyngeal carcinoma. J Clin Lab Anal 2002;16: 146-50.
25. Jalbout M, Bouaouina N, Gargouri J, Corbex M, Ben Ahmed S, Chouchane L. Polymorphism of the stress protein HSP70-2 gene is associated with the susceptibility to the nasopharyngeal carcinoma. Cancer Lett 2003;193:75-81.
26. Wihlborg C, Sjöberg J, Intaglietta M, Axdorph U, Pisa EK, Pisa P. Tumor necrosis factor-α cytokine promoter gene polymorphism in Hodgkin's disease and chronic lymphocytic leukaemia. Br J Haematol 1999;104:346-9.
27. Lu CC, Sheu BS, Chen TW, Yang HB, Hung KH, Kao AW, Chuang CH, et al. Host TNF-α -1031 and -863 promoter single nucleotide polymorphisms determine the risk of benign ulceration after H. pylori infection. Am J Gastroenterol 2005; 100:1274-82.
28. Soga Y, Nishimura F, Ohyama H, Maeda H, Takashiba S, Murayama Y. Tumor necrosis factor-alpha gene (TNF-alpha) -1031/-863, -857 single-nucleotide polymorphisms (SNPs) are associated with severe adult periodontitis in Japanese. J Clin Periodontol 2003;30:524-31.
29. Delgado JC, Leung JY, Baena A, Clavijo OP, Vittinghoff E, Buchbinder S, Wolinsky S, et al. The -1030/-862-linked TNF promoter single-nucleotide polymorphisms are associated with the inability to control HIV-1 viremia. Immunogenetics 2003; 55:497-501.
30. Date Y, Seki N, Kamizono S, Higuchi T, Hirata T, Miyata K, Ohkuni M, et al. Identification of a generic risk factor for systemic juvenile rheumatoid arthritis in the 5′-flanking region of the TNF-alpha gene and HLA genes. Arthritis Rheum 1999; 42:2577-82.
31. Nakajima K, Sasaki M, Nojima D, Oh BR, Ishii N, Miura K, Dahiya R, et al. Tumor necrosis factor-alpha gene mutations and genotype changes in renal cell carcinoma. J Urol 2001; 165:612-5.
32. Deshpande A, Nolan JP, White PS, Valdez YE, Hunt WC, Peyton CL, Wheeler CM. TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer. J Infect Dis 2005;191:969-76.
33. Yen JH, Chen CJ, Tsai WC, Lin CH, Ou TT, Wu CC, Liu HW. Tumor necrosis factor promoter polymorphisms in patients with rheumatoid arthritis in Taiwan. J Rheumatol 2001;28:1788-92.
34. Wu MS, Chen LT, Shun CT, Huang SP, Chiu HM, Wang HP, Lin MT, et al. Promoter polymorphisms of tumor necrosis factor-alpha are associated with risk of gastric mucosa-associated lymphoid tissue lymphoma. Int J Cancer 2004; 110:695-700.
35. Duan S, Xu Y, Chen W, Liu Z, Guo T, Gao J, Bian L, et al. No association between the promoter variants of tumor necrosis factor alpha (TNF-alpha) and schizophrenia in Chinese Han population. Neurosci Lett 2004;366:139-43.
36. Ma SL, Tang NL, Lam LC, Chiu HF. Association between tumor necrosis factor-alpha promoter polymorphism and Alzheimer's disease. Neurology 2004;62:307-9.